Yahoo
NYSE - Nasdaq Real Time Price USD

Hims & Hers Health, Inc. (HIMS)

28.61 +0.69 (+2.47%)
As of 12:21:36 PM EDT. Market Open.
Trade HIMS on Coinbase
Chart Range Bar
Loading chart for HIMS

What's happening with HIMS?

5m ago
Powered by Yahoo Scout

Hims & Hers is balancing rapid revenue growth against weaker profitability, lower gross margins, and regulatory scrutiny. Its testosterone launch and German expansion broaden the platform, while the November 9 earnings reportshould clarify demand, margins, and international performance.

Powered by Yahoo Scout
  • Previous Close 27.92
  • Open 27.71
  • Bid 28.50 x 30000
  • Ask 28.51 x 10000
  • Day's Range 27.72 - 28.91
  • 52 Week Range 13.74 - 48.46
  • Volume 4,331,709
  • Avg. Volume 11,163,642
  • Market Cap (intraday) 6.675B
  • Beta (5Y Monthly) 2.43
  • PE Ratio (TTM) --
  • EPS (TTM) -0.64
  • Earnings Date Nov 9, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 31.15
  • Morningstar Rating Rating available with Stock Picks access

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

www.hims.com

2,442

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HIMS
11.92%
S&P 500 (^GSPC)
13.02%

1-Year Return

HIMS
39.31%
S&P 500 (^GSPC)
12.27%

3-Year Return

HIMS
394.78%
S&P 500 (^GSPC)
87.90%

5-Year Return

HIMS
261.54%
S&P 500 (^GSPC)
68.32%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 753.21M
Earnings -86.29M
Profit Margin -11.46%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200M
400M
600M
-15.0%
-10.0%
-5.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

23.00 Low
31.15 Average
28.61 Current
42.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/24/2026
Analyst Truist Securities
Rating Action Maintains
Rating Hold
Price Action Raises
Price Target 27 -> 32

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.51%

  • Return on Assets (ttm)

    -2.21%

  • Return on Equity (ttm)

    -32.03%

  • Revenue (ttm)

    2.58B

  • Net Income Avi to Common (ttm)

    -142.03M

  • Diluted EPS (ttm)

    -0.64

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    841.05M

  • Total Debt/Equity (mrq)

    477.13%

  • Levered Free Cash Flow (ttm)

    849.44M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: